Cargando…

Functional Characterization and Anti-Tumor Effect of a Novel Group II Secreted Phospholipase A(2) from Snake Venom of Saudi Cerastes cerates gasperetti

Secreted phospholipases A(2) are snake-venom proteins with many biological activities, notably anti-tumor activity. Phospholipases from the same snake type but different geographical locations have shown similar biochemical and biological activities with minor differences in protein sequences. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonazi, Mona, Krayem, Najeh, Alharbi, Mona G., Khayyat, Arwa Ishaq A., Alanazi, Humidah, Horchani, Habib, Ben Bacha, Abir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536776/
https://www.ncbi.nlm.nih.gov/pubmed/37764293
http://dx.doi.org/10.3390/molecules28186517
Descripción
Sumario:Secreted phospholipases A(2) are snake-venom proteins with many biological activities, notably anti-tumor activity. Phospholipases from the same snake type but different geographical locations have shown similar biochemical and biological activities with minor differences in protein sequences. Thus, the discovery of a new phospholipase A(2) with unique characteristics identified in a previously studied venom could suggest the origins of these differences. Here, a new Group II secreted phospholipase A(2) (Cc-PLA(2)-II) from the snake venom of Saudi Cerastes cerastes gasperetti was isolated and characterized. The purified enzyme had a molecular weight of 13.945 kDa and showed high specific activity on emulsified phosphatidylcholine of 1560 U/mg at pH 9.5 and 50 °C with strict calcium dependence. Interestingly, stability in extreme pH and high temperatures was observed after enzyme incubation at several pH levels and temperatures. Moreover, a significant dose-dependent cytotoxic anti-tumor effect against six human cancer cell lines was observed with concentrations of Cc-PLA(2) ranging from 2.5 to 8 µM. No cytotoxic effect on normal human umbilical-vein endothelial cells was noted. These results suggest that Cc-PLA(2)-II potentially has angiogenic activity of besides cytotoxicity as part of its anti-tumor mechanism. This study justifies the inclusion of this enzyme in many applications for anticancer drug development.